Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
- 1 January 1985
- journal article
- research article
- Published by International Heart Journal (Japanese Heart Journal) in Japanese Heart Journal
- Vol. 26 (3) , 437-449
- https://doi.org/10.1536/ihj.26.437
Abstract
The effects of d1-2-(3''-t-butylamino-2''-hydroxypropylthio)-4-(5''-carbamoyl-2''-thienyl) thiazole hydrochloride (S-596) were evaluated in 9 normal volunteers. Exercise echocardiography was performed in the semi-supine position before and 2, 4 and 24 hours after the oral administration of 15 mg of S-596. Two hours after administration, resting heart rate was unchanged, compared with control, but systolic blood pressure at rest was slightly decreased (114 .+-. 6 vs. 106 .+-. 10 mmHg, P < 0.05). Left ventricular dimensions were unchanged, but shortening fraction was increased in the resting state (30.3 .+-. 4.6 vs. 33.1 .+-. 4.8%, P < 0.05). During exercise on oral S-596, heart rate and systolic blood pressure responses were reduced (127 .+-. 11 in control vs. 108 .+-. 6 beats/min on S-596, 198 .+-. 25 vs. 168 .+-. 23 mmHg, P < 0.001 and 0.05, respectively). Left ventricular end-diastolic dimension was not significantly altered by S-596 compared with the preceding control exercise test; however, end-systolic dimension was significantly larger after beta blockade with S-596 (2.6 .+-. 0.4 vs. 3.0 .+-. 0.4 cm, P < 0.05). Shortening fraction and cardiac output decreased significantly (43.7 .+-. 3.7 vs. 40.0 .+-. 5.7%, 9.5 .+-. 1.4 vs. 8.4 .+-. 1.3 L/min, P < 0.05 and 0.01, respectively). These effects of S-596 were maximal at 2 hours after oral administration with reduced response of heart rate to exercise lasting for 24 hours. Compared with the effects of propranolol (30 mg, given orally) in the same subjects, beta-adrenergic blockade during exercise with S-596 was equivalent to or greater than that of propranolol. Thus, S-596 has little, if any, effect on resting left ventricular performance, but demonstrates potent negative chronotropic and inotropic effects during exercise in normal human subjects. Its beta-adrenergic blocking action also has long acting properties, especially its chronotropic effect.This publication has 10 references indexed in Scilit:
- Left ventricular size and performance during graded supine exercise in normal subjects.Japanese Heart Journal, 1983
- Role of the Frank-Starling mechanism during maximal semisupine exercise after oral atenolol.Heart, 1982
- Effect of oral propranolol on rest, exercise and postexercise left ventricular performance in normal subjects and patients with coronary artery disease.Circulation, 1981
- Effects of oral propranolol on left ventricular size and performance during exercise and acute pressure loading.Circulation, 1980
- Echocardiographic evaluation of left ventricular size and performance during handgrip and supine and upright bicycle exercise.Circulation, 1979
- The predictable relationship between plasma levels and dose during chronic propranolol therapyClinical Pharmacology & Therapeutics, 1978
- Assessment of cardiac performance with quantitative radionuclide angiocardiography. Effects of oral propranolol on global and regional left ventricular function in coronary artery disease.Circulation, 1978
- Synthesis and β-Adrenergic Blocking Action of a New Thiazolylthiopropanolamine DerivativeJournal of Pharmaceutical Sciences, 1978
- Plasma concentrations of propranolol in patients with essential hypertensionEuropean Journal of Clinical Pharmacology, 1977
- Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions.Journal of Clinical Investigation, 1965